For researchers and students at the University of Oslo, researchers at Oslo University Hospital (OUS) and Akershus University Hospital (Ahus), members of The Life Science Cluster, LMI, Oslo Cancer Cluster, Norway Health Tech, the Oslo Science Park community and Oslo Science City partners. Free of charge, but you have to sign up.
The event is fully booked, and the registration is closed.
Programme
Inspirational talk: PHARMAQ's journey – from research to an innovation adventure
Helena Hauge, Senior Manager, PHARMAQ part of Zoetis
More about the talk, the speaker and the company
Helena Hauge is currently Associate Director and former Senior scientist member of the Virus Technology team in PHARMAQ part of Zoetis, conducting research and development of vaccines and innovations for aquaculture globally. She holds a PhD in cell biology/immunology from the University of Oslo. Before joining PHARMAQ in 2018, Helena worked 10 years as a scientist and project manager at the Norwegian Veterinary institute, focusing on virus-host interactions and vaccines for farmed fish using next-generation technologies. At PHARMAQ part of Zoetis it is all about making aquaculture progress to produce sustainable, safe and healthy seafood.
Helena will tell us about how PHARMAQ evolved from a Norwegian company into a part of a large international company. She will also shed light on work and career opportunities within the industry. The presentation will inspire and inform students and scientists about opportunities in the industry, for both employees and entrepreneurs.
PHARMAQ is the world's leading vaccine and innovation company focused on the aquaculture industry and part of Zoetis, the world's leading animal health company. The company develops safe and effective medicines for the aquaculture industry with a good environmental profile through targeted research and dedicated staff. Production, administration, research and development is located in Norway and the group's products are marketed in Europe, North and South America and in Asia. PHARMAQ has around 375 employees.
Role model talk
Armend H?ti, CEO, ClexBio
More the talk, the speaker and the company
Armend H?ti is the CEO and co-founder of the biotechnology company ClexBio. He is a former researcher and holds a PhD in biophysics from NTNU and Harvard, and has additional academic experience from his PostDoc at EPFL in Switzerland. In 2015, he was awarded one of Norway's best communicators on the televised show Researcher Grand Prix. His academic background is complemented with industry experience from his role as Director Product & Technology at Aker BioMarine where he was driving the development of new products for the company, including LYSOVETA?, which was launched last year. Armend is the co-author of 7 research papers and a co-inventor of more than 5 patents, including the CLEX technology that is fully owned by ClexBio.
At ClexBio, Armend's vision is to improve human health globally by growing transplant-ready human tissues in the laboratory. The company is currently developing their first product: Transplant-ready veins for millions of patients suffering from chronic venous insufficiency that currently have no permanent treatment options available. The ClexBio team currently consists of 7 full-time employees and is undergoing rapid growth. Since the company was founded in 2020, the team has raised approximately NOK 40 million from recognized biotechnology investors globally as well as various recognized grants. ClexBio owns several patents on innovations that enable the production of human tissue in the laboratory.
Meet the student innovation associations at UiO
Why do the student innovation associations at the University of Oslo want to collaborate with industry, and how do they want to collaborate?
- Elham Koroud, The Student Association for Medical Innovation
- Karoline Sandbakken, The Student Association for Pharmaceutical Innovation
- Sindre Tangen, Innovation at the Department of Chemistry
Meet the companies
Companies that are members of the Life Science Cluster will give give a 2-minute pitch on their company to let researchers and students know what the company is all about and what they can discuss with representatives from the company at the matchmaking.
Matchmaking
The companies are available for matchmaking with researchers and students after the talks and pitches.
Food and beverages, and mingling at the new rooftop terrace in Oslo Science Park
About the innovation hangouts
The Life Science Growth House will arrange quarterly afternoon/evening-innovation hangouts.
This is an informal meeting place where students and researchers from the University of Oslo (UiO) can interact with actors from the public sector, hospitals, companies, mentors, business clusters and incubators within UiO's innovation ecosystem. We will provide inspirational talks, talks from role models, matchmaking, food and beverages, and mingling.
The overall goal of the Life Science Growth House is to strengthen the innovation culture at UiO to put more knowledge from research to use. With this meeting place, we want to inspire researchers and students, give them self-confidence and knowledge about the innovation process, help them build networks, and facilitate collaboration between academia and industry.